Cargando…
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial
Rationale: Although early antimicrobial discontinuation guided by procalcitonin (PCT) has shown decreased antibiotic consumption in lower respiratory tract infections, the outcomes in long-term sepsis sequelae remain unclear. Objectives: To investigate if PCT guidance may reduce the incidence of lon...
Autores principales: | Kyriazopoulou, Evdoxia, Liaskou-Antoniou, Lydia, Adamis, George, Panagaki, Antonia, Melachroinopoulos, Nikolaos, Drakou, Elina, Marousis, Konstantinos, Chrysos, Georgios, Spyrou, Andronikos, Alexiou, Nikolaos, Symbardi, Styliani, Alexiou, Zoi, Lagou, Styliani, Kolonia, Virginia, Gkavogianni, Theologia, Kyprianou, Miltiades, Anagnostopoulos, Ioannis, Poulakou, Garyfallia, Lada, Malvina, Makina, Anna, Roulia, Efrosyni, Koupetori, Marina, Apostolopoulos, Vasileios, Petrou, Dimitra, Nitsotolis, Thomas, Antoniadou, Anastasia, Giamarellos-Bourboulis, Evangelos J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874409/ https://www.ncbi.nlm.nih.gov/pubmed/32757963 http://dx.doi.org/10.1164/rccm.202004-1201OC |
Ejemplares similares
-
Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19
por: Kassianidis, Georgios, et al.
Publicado: (2022) -
The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
por: Karaiskos, Ilias, et al.
Publicado: (2019) -
BioFire(®) FilmArray(®) Pneumonia Panel for Severe Lower Respiratory Tract Infections: Subgroup Analysis of a Randomized Clinical Trial
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021) -
Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis*
por: Karakike, Eleni, et al.
Publicado: (2021) -
Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: The AIDA open label, randomized, controlled Phase 4 trial
por: Kotsaki, Antigone, et al.
Publicado: (2022)